Clinical Trials
108
Active:90
Completed:5
Trial Phases
4 Phases
Phase 1:82
Phase 2:4
Phase 3:6
+1 more phases
Drug Approvals
13
NMPA:5
CANADA:3
FDA:2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (95 trials with phase data)• Click on a phase to view related trials
Phase 1
82 (86.3%)Phase 3
6 (6.3%)Phase 2
4 (4.2%)phase_1_2
2 (2.1%)Phase 4
1 (1.1%)No trials found
News
Metformin Shows Potential Survival Benefit in HER2-Positive Breast Cancer Patients
A comprehensive scoping review of 40 clinical trials published in BMC Cancer reveals that metformin may modestly increase pathologic complete response rates in HER2-positive breast cancer patients when added to standard treatment regimens.
RESTEM Receives FDA Orphan Drug Designation for Stem Cell Therapy in Polymyositis Treatment
RESTEM, a clinical-stage biotech company, received FDA Orphan Drug Designation in December 2024 for its umbilical cord outer lining stem cell program targeting polymyositis and dermatomyositis.